The epidemiology of venous thromboembolism

Journal of Thrombosis and Thrombolysis
John A HeitRichard H White

Abstract

Venous thromboembolism (VTE) is categorized by the U.S. Surgeon General as a major public health problem. VTE is relatively common and associated with reduced survival and substantial health-care costs, and recurs frequently. VTE is a complex (multifactorial) disease, involving interactions between acquired or inherited predispositions to thrombosis and VTE risk factors, including increasing patient age and obesity, hospitalization for surgery or acute illness, nursing-home confinement, active cancer, trauma or fracture, immobility or leg paresis, superficial vein thrombosis, and, in women, pregnancy and puerperium, oral contraception, and hormone therapy. Although independent VTE risk factors and predictors of VTE recurrence have been identified, and effective primary and secondary prophylaxis is available, the occurrence of VTE seems to be relatively constant, or even increasing.

References

Jun 1, 1983·The American Journal of Medicine·S Z GoldhaberM Feinleib
Jan 24, 1994·Archives of Internal Medicine·A CogoA Girolami
Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Aug 13, 1997·JAMA : the Journal of the American Medical Association·D GradyC Furberg
Oct 29, 1997·Archives of Internal Medicine·A G van den BeltM H Prins
Mar 14, 1998·Annals of Internal Medicine·L Chasan-Taber, M J Stampfer
Jul 15, 1998·British Journal of Clinical Pharmacology·C R Meier, H Jick
Mar 29, 2000·Archives of Internal Medicine·P O HanssonH Eriksson
Jun 1, 2000·The American Journal of Cardiology·A L KlatskyJ Poggi
Dec 15, 2000·The New England Journal of Medicine·R H WhiteP S Romano
Feb 15, 2001·American Journal of Obstetrics and Gynecology·D R Danilenko-DixonL J Melton
Aug 3, 2001·Archives of Internal Medicine·J G RayA Laupacis
Jul 21, 2001·The New England Journal of Medicine·G AgnelliUNKNOWN Warfarin Optimal Duration Italian Trial Investigators
Aug 10, 2001·JAMA : the Journal of the American Medical Association·J MerrerUNKNOWN French Catheter Study Group in Intensive Care
Nov 13, 2001·Mayo Clinic Proceedings·J A HeitW M O'Fallon
May 22, 2002·JAMA : the Journal of the American Medical Association·Isabelle ArnulfJean-Philippe Derenne
Jun 1, 2002·Archives of Internal Medicine·John A HeitL Joseph Melton
Oct 24, 2002·Blood·Mary CushmanSusan R Heckbert
Dec 18, 2002·Annals of Internal Medicine·Paolo PrandoniAntonio Girolami
Apr 5, 2003·Thrombosis Research·W Craig HooperNathaniel Cobb
Apr 11, 2003·The New England Journal of Medicine·Paolo PrandoniAntonio Girolami
Jul 2, 2003·Annals of Internal Medicine·Giancarlo AgnelliUNKNOWN Warfarin Optimal Duration Italian Trial Investigators

❮ Previous
Next ❯

Citations

Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Jack E Ansell
Apr 3, 2016·Disease-a-month : DM·Harry E FuentesJoseph A Caprini
Aug 23, 2016·Acta Ophthalmologica·Claudia Kuhli-HattenbachLars-Olof Hattenbach
Aug 19, 2016·Expert Opinion on Drug Safety·Daniela MastroiacovoFrancesco Dentali
Oct 16, 2016·The American Journal of Cardiology·Praveen HariharanChristopher Kabrhel
Aug 16, 2016·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·E RyanM J Lee
Aug 3, 2016·Bulletin du cancer·Grigoris T Gerotziafas, Ismail Elalamy
Sep 30, 2016·Fertility and Sterility·Regine Sitruk-Ware
Oct 16, 2016·Journal of Thrombosis and Thrombolysis·Chrisanna DobrowolskiManish M Sood
Mar 18, 2017·Current Opinion in Hematology·Jordan K SchaeferSuman L Sood
Apr 14, 2017·Hospital Practice·Christopher KabrhelNicholas Giordano
Apr 4, 2018·Internal and Emergency Medicine·Eleonora Tamborini PermunianAlessandro Squizzato
Mar 24, 2018·Current Opinion in Nephrology and Hypertension·Justin Ashley, Manish M Sood
Oct 19, 2017·The Clinical Respiratory Journal·Elif Yilmazel UcarLeyla Saglam
Nov 21, 2017·Research and Practice in Thrombosis and Haemostasis·Oluwaseun E FashanuAaron R Folsom
Apr 4, 2017·Biomolecules & Therapeutics·Joo Hee KimHye Sun Gwak
Jun 13, 2018·Journal of Thrombosis and Haemostasis : JTH·Benjamin BouyerJoël Coste
Jul 6, 2018·Journal of Thrombosis and Haemostasis : JTH·L B HarringtonM K Jensen
Jul 12, 2018·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Licínio MancoM Letícia Ribeiro
Sep 27, 2018·Expert Review of Hematology·Gualtiero Palareti, Daniela Poli
Feb 2, 2018·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Apr 27, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Alisa S Wolberg
Jul 26, 2017·Circulation Research·Tatyana PonomaryovAlexander Brill
Sep 25, 2018·Journal of Thrombosis and Haemostasis : JTH·J J López-NúñezM Monreal
Sep 7, 2018·Acta Obstetricia Et Gynecologica Scandinavica·Michael Due LarsenGunnar Lose
Sep 22, 2018·Journal of Thrombosis and Haemostasis : JTH·N A ZakaiP L Lutsey
Dec 28, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshikazu Matsuoka, Hiroshi Morimatsu
Feb 8, 2019·Journal of Thrombosis and Thrombolysis·Phil WellsConcetta Crivera
Jun 27, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jona Lekura, James S Kalus

❮ Previous
Next ❯

Methods Mentioned

BETA
total hip arthroplasty
contraception

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.